Centroblastic-centrocytic non-Hodgkin's lymphoma Stage I-III: Patterns of failure following radiotherapy

Strahlentherapie und Onkologie

Volumn 177, Issue 11, 2001, Pages 597-603

  Frank, Claudia ^a   Zierhut, Dietmar ^a   Schulz Ertner, Daniela ^a   Wannenmacher, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Centroblastic centrocytic non Hodgkin's lymphoma; Low grade non Hodgkin's lymphoma; Radiotherapy; Relapse analysis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; RADIATION DOSE; TREATMENT FAILURE;

EID: 0035155650     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002370     Document Type: Article

References (55)

1. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma
2. Radiation therapy of localized non-Hodgkin's lymphoma
3. Report of the committee on Hodgkin's disease staging classification
4. Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: The 1975-1980 EORTC controlled lymphoma trial
5. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma
6. Regression models and life tables
7. Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? Long-term experience at a single institution
8. The follicular non-Hodgkin's lymphomas - I. The possibility of cure
9. The follicular non-Hodgkin's lymphomas - II. Prognostic factors: What do they mean?
10. Stage I and II low grade non-Hodgkin's lymphoma: Prognostic factors and treatment results
11. Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809
12. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission
13. Patterns of presentation and relapse in the non-Hodgkin's lymphomata
14. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas
15. Prognostic factors in nodular lymphomas: A multivariate analysis based on the Princess Margaret Hospital experience
16. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma
17. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
18. Central lymphatic irradiation for stage III nodular malignant lymphoma: Long term results
19. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma
20. Nonparametric estimation from incomplete observations
21. The treatment of Hodgkin's disease
22. A British National Investigation randomized trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localized non-Hodgkin's lymphoma
23. Chlorambucil/prednisone vs CHOP in symptomatic low-grade non-Hodgkin's lymphomas: A randomized trial from the lymphoma group of central Sweden
24. CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas
25. Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute
26. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
27. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University
28. Stage I-II follicular lymphoma. Treatment results for 76 patients
29. Comprehensive lymphatic irradiation for stage II-III non-Hodgkin's lymphoma
30. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma
31. CC-CB Non-Hodgkin-Lymphome: Behandlungsergebnisse in den Stadien I-II
32. High activity of daily-schedule mitoxantrone in newly diagnosed low-grade non-Hodgkin's lymphomas: A 5-year follow up
33. Analysis of non Hodgkin's lymphomas with nodular and favorable histologies, stages I and II
34. The role of radiation therapy in the management of stage III follicular lymphomas
35. Survival in localized nodal and extranodal non-Hodgkin's lymphomata
36. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma
37. Analysis of failures after whole abdominal irradiation in gastrointestinal lymphomas. Is prophylactic irradiation of inguinal lymph nodes required?
38. Strahlenbehandlung von follikulären keimzentrumslymphomen
39. The CUP trial: A randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)
40. High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma
41. Die bedeutung einer umfassenden strahlentherapie für die prognose des zentroblastisach-zentrozytischen lymphoms bzw. des grossfollikulären lymphoms brill-symmers (Freiburger Ergebnisse 1965-1979)
42. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: Final analysis of survival and toxicity in the groupe d'etude des lymphomes folliculaires 86 trial
43. Localized follicular lymphomas: Prognosis and survival of stages I and II in a retrospective series of 103 patients
44. Updated Kiel classification for lymphomas
45. Extended field and total central Lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic non-Hodgkin's lymphoma
46. Role of radiation therapy in localized non-Hodgkin's lymphoma
47. Low grade stage I and II non-Hodgkin's lymphoma: Results of treatment and relapse pattern following therapy
48. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma
49. Allogeneic bone marrow transplantation for low grade lymphoma
50. Clinical stage I non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the british national lymphoma investigation with radiotherapy alone as initial therapy
51. Multicenter Phase II Study of Iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
52. Relevance of positron emission tomography (PET) in Oncology
53. Adjuvant Cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study